1. Mason JO 3rd, White MF, Feist RM, et al. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina. 2008; 28:564–7.
Article
2. Jonas JB, Spandau UH, Schlichtenbrede F. Short-term complications of intravitreal injections of triamcinolone and bevacizumab. Eye. 2008; 22:590–1.
Article
3. Roth DB, Realini T, Feuer WJ, et al. Short-term complications of intravitreal injection of triamcinolone acetonide. Retina. 2008; 28:66–70.
Article
4. Chu NS, Chan-Myers H, Ghazanfari N, Antonoplos P. Levels of naturally occurring microorganisms on surgical instruments after clinical use and after washing. Am J Infect Control. 1999; 27:315–9.
Article
5. Rutala WA, Gergen MF, Jones JF, Weber DJ. Levels of microbial contamination on surgical instruments. Am J Infect Control. 1998; 26:143–5.
Article
6. American Society of Cataract and Refractive Surgery American Society of Ophthalmic Registered Nurses. Recommended practices for cleaning and sterilizing intraocular surgical instruments. Insight. 2007; 32:22–8.
7. Fedorowsky R, Madar H, Dori L, et al. Staphylococcal infections in PD: monitoring, screening and prevention. EDTNA ERCA J. 2005; 31:10–2.
Article
8. Wade JC, Schimpff SC, Newman KA, Wiernik PH. Staphy-lococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med. 1982; 97:503–8.
Article
9. Lalwani GA, Flynn HW Jr, Scott IU, et al. Acute-onset endo-phthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology. 2008; 115:473–6.
10. Kunimoto DY, Das T, Sharma S, et al. Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group. Am J Ophthalmol. 1999; 128:240–2.
11. Iwatsuki K, Yamasaki O, Morizane S, Oono T. Staphylococcal cutaneous infections: Invasion, evasion and aggression. J Dermatol Sci. 2006; 42:203–14.
Article
12. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina. 2004; 24:676–98.
Article
13. Kermode M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int. 2004; 19:95–103.
Article
14. Hutin Y, Hauri A, Chiarello L, et al. Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bull World Health Organ. 2003; 81:491–500.
15. Daly AD, Nxumalo MP, Biellik RJ. An assessment of safe injection practices in health facilities in Swaziland. S Afr Med J. 2004; 94:194–7.